Skip to main content
. Author manuscript; available in PMC: 2024 Nov 18.
Published in final edited form as: Lancet Oncol. 2023 Sep 1;24(9):1018–1028. doi: 10.1016/S1470-2045(23)00335-2

Figure 1. Cumulative incidence of high-grade serous tubo-ovarian cancer from randomisation until Dec 31, 2014, by screening group.

Figure 1

Shaded areas are 95% CI.